Feasibility of screening patients for emotional risk factors before in vitro fertilization in daily clinical practice: a process evaluation

• Published in: Human reproduction (Oxford) 2012-12, Vol.27 (12), p.3493-3501
• Main Authors: Van Dongen, A.J.C.M., Kremer, J.A.M., Van Sluisveld, N., Verhaak, C.M., Nelen, W.L.D.M.
• Format: Article
• Language: English
• Subjects: Adult; Affective Symptoms - etiology; Affective Symptoms - psychology; Biological and medical sciences; Cohort Studies; Emotions; Feasibility Studies; Female; Fertilization in Vitro - psychology; Gynecology. Andrology. Obstetrics; Humans; Infertility - ethnology; Infertility - psychology; Internet; Male; Medical sciences; Outcome and Process Assessment (Health Care); Prospective Studies; Risk Factors; Surveys and Questionnaires; Therapy, Computer-Assisted
• ISSN: 0268-1161; 1460-2350
• DOI: 10.1093/humrep/des324

STUDY QUESTION Is patient screening for emotional risk factors before starting IVF treatment feasible? SUMMARY ANSWER Introduction of screening for emotional risk factors by a validated instrument (SCREENIVF) in couples treated by IVF or ICSI is feasible, indicated by a moderate to high and stable uptake rate, a high acceptance of the process of SCREENIVF, and a high acceptability of the presented risk profile by the patients. WHAT IS KNOWN ALREADY SCREENIVF is a validated screening tool to identify women at risk for emotional maladjustment preceding the start of their IVF/ICSI treatment. STUDY DESIGN, SIZE AND DURATION This was a prospective cohort study, including data of two cohorts of patients (304 and 342 patients), with a duration of 3 months per cohort. For the first cohort, we sent a process evaluation to 210 patients and it was completed by 91 patients. PARTICIPANTS/MATERIALS, SETTING AND METHODS All 304 patients (male and female) who started IVF/ICSI between 1 December 2009 and 28 February 2010 in our tertiary IVF clinic were eligible. The uptake rate of SCREENIVF was assessed as the response rate to the screening questionnaire. One year later, we re-assessed the uptake rate in 342 new patients to assess the stability of the uptake rate. A non-responder assessment in patients who did not complete SCREENIVF was carried out. Finally, patients' characteristics and their experiences with SCREENIVF as well as their consequent actions were assessed by an additional process evaluation questionnaire sent some months later to 210 patients. MAIN RESULTS AND THE ROLE OF CHANCE The uptake rate of SCREENIVF was 78–80%. One-third of the responders were found to be at risk for emotional maladjustment, which was comparable with previous studies using SCREENIVF. Of 27 non-responders to SCREENIVF, 41% explained non-response by ‘no actual need for psychological help’ and 19% forgot to complete the screening. The response rate to the process evaluation was 43% (n = 91). Of these, 90% found the screening was useful, and almost all patients were positive about the SCREENIVF questionnaire. Furthermore, 93% recognized themselves in the risk profile based on SCREENIVF. Of the patients at risk, 21% reported planning to seek professional help, but 46% of the at-risk patients experienced travelling distance as an obstacle to seek psychological help. We concluded that screening patients for emotional risk factors is feasible. In future, psychosocial care offered by the Inter